Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | -0.93% | 291.40 | 1.4% | $865.23m | |
| AMGN | Amgen, Inc. | 0.28% | 221.31 | 1.3% | $495.03m | |
| CELG | Celgene Corp. | 0.39% | 110.00 | 1.3% | $448.97m | |
| GILD | Gilead Sciences, Inc. | -0.50% | 64.32 | 1.0% | $384.61m | |
| ILMN | Illumina, Inc. | 0.25% | 295.73 | 3.5% | $305.32m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.97% | 203.86 | 1.9% | $290.09m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.20% | 348.41 | 2.6% | $262.04m | |
| EXAS | EXACT Sciences Corp. | -0.77% | 79.91 | 24.0% | $196.13m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.39% | 109.44 | 2.0% | $190.16m | |
| SGEN | Seattle Genetics, Inc. | 2.16% | 110.64 | 6.1% | $126.52m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.73% | 75.88 | 4.3% | $110.72m | |
| SRPT | Sarepta Therapeutics, Inc. | 5.46% | 99.95 | 14.6% | $106.88m | |
| A | Agilent Technologies, Inc. | 0.26% | 77.05 | 1.6% | $100.02m | |
| MRTX | Mirati Therapeutics, Inc. | 1.12% | 104.33 | 2.3% | $89.09m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.50% | 111.40 | 5.0% | $84.24m |
Company Profile
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.